Please login to the form below

McKinsey

This page shows the latest McKinsey news and features for those working in and with pharma, biotech and healthcare.

Keeping it in the family pays dividends

It is clear the benefits leach into culture as a McKinsey survey of businesses owned by families and founders showed that 90% of board members said that family values were present

Latest news

I, Robot: How AI is redefining the use of data in healthcare

McKinsey's analysis of this space has recently suggested that the use of data handling strategies for pharmaceutical research could create up to $100bn in cost savings per year, and that
A new era of collaboration

A study by McKinsey found that if spending on health increases at the current rate, it will reach 50% of the GDP in most Organisation for Economic Cooperation and Development (OECD)
The Digital Patient

A 2014 survey from McKinsey &Co showed that three quarters of consumers in the UK, Germany and Singapore would like to make use of digital healthcare services – contrary to the perceived ... The McKinsey survey also exploded the myth that only younger
Novo Nordisk will work with IBM on diabetes care

hold the key to revolutionising R&D and accelerating productivity - as laid out in a McKinsey &Co report published in 2013.
Teva takes controlling stake in genomics specialist

A 2013 report on personalised medicine by McKinsey &Co acknowledged the "tremendous potential" for this type of approach in CNS diseases whilst noting it is still in its infancy.

More from news
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest Intelligence

Diversity and inclusion in the pharma industry

This year McKinsey’s Delivering Through Diversity report reiterated this and showed that the companies with more diverse senior leadership groups are a third more likely to outperform their competitors.
How can pharma build bridges with HCPs online?

According to a recent report from McKinsey &Company: ‘81% of physicians are dissatisfied with their interactions with biopharmaceutical companies, and more than 40% no longer perceive a “need”for medical support ... However, the recent report from
The Big Book of Dashboards

Steve Wexler has worked with ADP, Gallup, Deloitte, Convergys, Consumer Reports, The Economist, ConEd, D&B, Marist, Tradeweb, Tiffany, McKinsey &Company, and many other organisations to help them understand and visualise
A new era of smart pharma

According to the McKinsey Global Institute, it is estimated that, by applying big data strategies to better inform decision-making, the United States could generate up to $100bn in value annually ... The McKinsey Global Institute expects that, within
Can value-based healthcare take off and reach for the skies?

they do badly, ”added Mr Moran, who joined Novartis from McKinsey &Company as a strategic assistant to the CEO in January 2015.

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest appointments

BMS appoints Saurabh Saha as senior VP, global head of translational medicine

His other roles include consultant at McKinsey and Company and director and head of the new indications discovery unit at Novartis.
Sandoz UK promotes Tim de Gavre to country head

Prior that that he worked at McKinsey &Company and brings almost 20 years of healthcare, consulting and marketing experience to the firm.
Targovax appoints chief financial officer

He also brings experience from cancer biotech Algeta ASA, and management consulting expertise from McKinsey &Company's pharma and healthcare practice.
Nouscom appoints COO and board members

Prior to this, she was the global head of neurodegeneration at Novartis, and worked in the healthcare sector of McKinsey &Company in Chicago.
The Medicines Company appoints Biogen's Tony Kingsley

Kingsley also previously worked as a partner at McKinsey &Company focusing on the biotechnology, pharmaceutical and medical device industries.

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

Digital trends in B2B sales - how far behind is Pharma?

Following a survey from McKinsey, research has demonstrated that the fastest-growing B2B companies use digital and inside sales channels more effectively than slower-growing companies. ... McKinsey continues that this modern approach to B2B sales is “
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?

Willing to pay more. Research conducted by McKinsey has shown that on the one hand, 67% of the middle class are willing to pay more for branded medication perceived as “ trustworthy”
McKinsey & Company

McKinsey &Company. McKinsey is a management consulting firm that helps leading organisations improve their performance. ... McKinsey &Company.